

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 9.21866007 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 8.63476672 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 8.63476672 |
| 4 | * respiratory electron transport chain (GO:0022904) | 7.00078047 |
| 5 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.97723085 |
| 6 | * electron transport chain (GO:0022900) | 6.82193751 |
| 7 | oxidative phosphorylation (GO:0006119) | 6.26130988 |
| 8 | ATP biosynthetic process (GO:0006754) | 5.13708671 |
| 9 | protein complex biogenesis (GO:0070271) | 4.88117665 |
| 10 | chaperone-mediated protein transport (GO:0072321) | 4.76913508 |
| 11 | regulation of mitochondrial translation (GO:0070129) | 4.67689409 |
| 12 | ribosomal small subunit assembly (GO:0000028) | 4.62720554 |
| 13 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.52016057 |
| 14 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 4.50270453 |
| 15 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 4.47464947 |
| 16 | cytochrome complex assembly (GO:0017004) | 4.40063104 |
| 17 | regulation of oxidative phosphorylation (GO:0002082) | 4.26126512 |
| 18 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.24327185 |
| 19 | termination of RNA polymerase III transcription (GO:0006386) | 4.24327185 |
| 20 | * hydrogen ion transmembrane transport (GO:1902600) | 4.23140418 |
| 21 | NADH dehydrogenase complex assembly (GO:0010257) | 4.16985139 |
| 22 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.16985139 |
| 23 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.16985139 |
| 24 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.04525303 |
| 25 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 4.04274911 |
| 26 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.00576878 |
| 27 | negative regulation of ligase activity (GO:0051352) | 4.00308804 |
| 28 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.00308804 |
| 29 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.82297361 |
| 30 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.82297361 |
| 31 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.81017569 |
| 32 | proteasome assembly (GO:0043248) | 3.79688573 |
| 33 | removal of superoxide radicals (GO:0019430) | 3.78788158 |
| 34 | cellular response to superoxide (GO:0071451) | 3.78788158 |
| 35 | cellular response to oxygen radical (GO:0071450) | 3.78788158 |
| 36 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.73660390 |
| 37 | hydrogen peroxide catabolic process (GO:0042744) | 3.70516522 |
| 38 | inner mitochondrial membrane organization (GO:0007007) | 3.69464796 |
| 39 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.68156313 |
| 40 | heme biosynthetic process (GO:0006783) | 3.67465033 |
| 41 | * proton transport (GO:0015992) | 3.65776448 |
| 42 | heart process (GO:0003015) | 3.61042751 |
| 43 | heart contraction (GO:0060047) | 3.61042751 |
| 44 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.59329712 |
| 45 | * hydrogen transport (GO:0006818) | 3.58951637 |
| 46 | tricarboxylic acid cycle (GO:0006099) | 3.57803814 |
| 47 | maturation of SSU-rRNA (GO:0030490) | 3.57660849 |
| 48 | translational elongation (GO:0006414) | 3.55712606 |
| 49 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.55472256 |
| 50 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.55312371 |
| 51 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.55312371 |
| 52 | rRNA modification (GO:0000154) | 3.51684244 |
| 53 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.51119782 |
| 54 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.51119782 |
| 55 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.50258837 |
| 56 | cellular ketone body metabolic process (GO:0046950) | 3.48414057 |
| 57 | respiratory chain complex IV assembly (GO:0008535) | 3.45357097 |
| 58 | aerobic respiration (GO:0009060) | 3.45029794 |
| 59 | mitochondrial transport (GO:0006839) | 3.44416044 |
| 60 | pseudouridine synthesis (GO:0001522) | 3.42915314 |
| 61 | aldehyde catabolic process (GO:0046185) | 3.41743805 |
| 62 | ribosomal large subunit biogenesis (GO:0042273) | 3.40061303 |
| 63 | establishment of integrated proviral latency (GO:0075713) | 3.38497507 |
| 64 | positive regulation of ligase activity (GO:0051351) | 3.37327828 |
| 65 | protein targeting to mitochondrion (GO:0006626) | 3.36081088 |
| 66 | heme metabolic process (GO:0042168) | 3.35378574 |
| 67 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.32763992 |
| 68 | translational initiation (GO:0006413) | 3.27941984 |
| 69 | protein-cofactor linkage (GO:0018065) | 3.27104171 |
| 70 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.26766197 |
| 71 | cytidine deamination (GO:0009972) | 3.25945204 |
| 72 | cytidine metabolic process (GO:0046087) | 3.25945204 |
| 73 | cytidine catabolic process (GO:0006216) | 3.25945204 |
| 74 | GTP biosynthetic process (GO:0006183) | 3.23865775 |
| 75 | protein deneddylation (GO:0000338) | 3.23452942 |
| 76 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.21875693 |
| 77 | DNA deamination (GO:0045006) | 3.21499916 |
| 78 | cellular component biogenesis (GO:0044085) | 3.21389220 |
| 79 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.21194627 |
| 80 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.21023833 |
| 81 | spliceosomal snRNP assembly (GO:0000387) | 3.21012248 |
| 82 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.20242222 |
| 83 | establishment of protein localization to mitochondrion (GO:0072655) | 3.20195557 |
| 84 | protein neddylation (GO:0045116) | 3.19996854 |
| 85 | GDP-mannose metabolic process (GO:0019673) | 3.19304547 |
| 86 | regulation of cellular respiration (GO:0043457) | 3.18963562 |
| 87 | viral life cycle (GO:0019058) | 3.17958769 |
| 88 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.16884231 |
| 89 | regulation of cellular amine metabolic process (GO:0033238) | 3.16397596 |
| 90 | cellular protein complex disassembly (GO:0043624) | 3.13827476 |
| 91 | cullin deneddylation (GO:0010388) | 3.13122546 |
| 92 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.09856322 |
| 93 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.08100475 |
| 94 | intracellular protein transmembrane import (GO:0044743) | 3.07652394 |
| 95 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 3.07625196 |
| 96 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.06091452 |
| 97 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.06091452 |
| 98 | hydrogen peroxide metabolic process (GO:0042743) | 3.05381872 |
| 99 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.04920188 |
| 100 | regulation of ligase activity (GO:0051340) | 3.03256167 |
| 101 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.03076015 |
| 102 | protein localization to mitochondrion (GO:0070585) | 3.03074786 |
| 103 | ribonucleoside monophosphate biosynthetic process (GO:0009156) | 3.01225881 |
| 104 | cotranslational protein targeting to membrane (GO:0006613) | 3.00138711 |
| 105 | protein targeting to ER (GO:0045047) | 3.00133721 |
| 106 | viral transcription (GO:0019083) | 2.99929693 |
| 107 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.98132532 |
| 108 | ketone body metabolic process (GO:1902224) | 2.97922132 |
| 109 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.97710795 |
| 110 | nucleoside monophosphate biosynthetic process (GO:0009124) | 2.96463422 |
| 111 | negative regulation of mitochondrion organization (GO:0010823) | 2.95210683 |
| 112 | purine nucleoside biosynthetic process (GO:0042451) | 2.94293412 |
| 113 | purine ribonucleoside biosynthetic process (GO:0046129) | 2.94293412 |
| 114 | NADH metabolic process (GO:0006734) | 2.93599527 |
| 115 | iron-sulfur cluster assembly (GO:0016226) | 2.92615173 |
| 116 | metallo-sulfur cluster assembly (GO:0031163) | 2.92615173 |
| 117 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.91796004 |
| 118 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.91330166 |
| 119 | translation (GO:0006412) | 2.90808211 |
| 120 | 7-methylguanosine mRNA capping (GO:0006370) | 2.89335550 |
| 121 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.89320063 |
| 122 | protein localization to endoplasmic reticulum (GO:0070972) | 2.89246143 |
| 123 | ribosomal small subunit biogenesis (GO:0042274) | 2.88666988 |
| 124 | sequestering of actin monomers (GO:0042989) | 2.88209130 |
| 125 | establishment of viral latency (GO:0019043) | 2.87884245 |
| 126 | DNA damage response, detection of DNA damage (GO:0042769) | 2.87484099 |
| 127 | 7-methylguanosine RNA capping (GO:0009452) | 2.85657704 |
| 128 | RNA capping (GO:0036260) | 2.85657704 |
| 129 | translational termination (GO:0006415) | 2.85626608 |
| 130 | response to oxygen radical (GO:0000305) | 2.85448056 |
| 131 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.85201791 |
| 132 | UTP biosynthetic process (GO:0006228) | 2.84015017 |
| 133 | response to superoxide (GO:0000303) | 2.83825308 |
| 134 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.81522737 |
| 135 | chromatin remodeling at centromere (GO:0031055) | 2.80667642 |
| 136 | ADP metabolic process (GO:0046031) | 2.79407027 |
| 137 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.79348467 |
| 138 | regulation of metalloenzyme activity (GO:0048552) | 2.77134836 |
| 139 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.75752460 |
| 140 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.75752460 |
| 141 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.74645897 |
| 142 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.74395692 |
| 143 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.74395692 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.48212735 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.09641716 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.05251069 |
| 4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.54487149 |
| 5 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.30390251 |
| 6 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.28762027 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.19613286 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.15485767 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.14107508 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.92318292 |
| 11 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.90865978 |
| 12 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.80518467 |
| 13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.67342115 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.55360759 |
| 15 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.50424283 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.44770115 |
| 17 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.37484365 |
| 18 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.31527858 |
| 19 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.31096611 |
| 20 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.30053575 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.27812782 |
| 22 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.25781620 |
| 23 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.24885725 |
| 24 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.20530606 |
| 25 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.15208807 |
| 26 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.14845383 |
| 27 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.00952110 |
| 28 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.99539918 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.98850103 |
| 30 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.95372841 |
| 31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.90237713 |
| 32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89581186 |
| 33 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.84865938 |
| 34 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.79253986 |
| 35 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.77306032 |
| 36 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.70929554 |
| 37 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.63709653 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.63684976 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62475451 |
| 40 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.61840206 |
| 41 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.61533980 |
| 42 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.61223051 |
| 43 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.60784811 |
| 44 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.59032225 |
| 45 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.58349777 |
| 46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.57681615 |
| 47 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.51918652 |
| 48 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.51080372 |
| 49 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.49891744 |
| 50 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48583766 |
| 51 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.47827144 |
| 52 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.41091620 |
| 53 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.35728064 |
| 54 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.32432821 |
| 55 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.30245317 |
| 56 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.29457525 |
| 57 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.28806611 |
| 58 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28450603 |
| 59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27813166 |
| 60 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.27571213 |
| 61 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.27391862 |
| 62 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.25874162 |
| 63 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.24847346 |
| 64 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.24171361 |
| 65 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.23262382 |
| 66 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.21321125 |
| 67 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.20828698 |
| 68 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.20727540 |
| 69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.20209524 |
| 70 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.19650835 |
| 71 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.18717104 |
| 72 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.18608365 |
| 73 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.18511809 |
| 74 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17167088 |
| 75 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.15404508 |
| 76 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.15362023 |
| 77 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.14343995 |
| 78 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.12909341 |
| 79 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.11140896 |
| 80 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.11095373 |
| 81 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10822444 |
| 82 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.10477532 |
| 83 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.10178698 |
| 84 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.09885103 |
| 85 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.09523630 |
| 86 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.09506226 |
| 87 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.08212892 |
| 88 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05473960 |
| 89 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.04994658 |
| 90 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.04900042 |
| 91 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.04086136 |
| 92 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.03442274 |
| 93 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.02811800 |
| 94 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.02753553 |
| 95 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.02634837 |
| 96 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.99806805 |
| 97 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.98563120 |
| 98 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.98431195 |
| 99 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97459096 |
| 100 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.96434869 |
| 101 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.95381251 |
| 102 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94356505 |
| 103 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93347637 |
| 104 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.93307164 |
| 105 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.92310118 |
| 106 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.92117872 |
| 107 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92117456 |
| 108 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.90917307 |
| 109 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.90786471 |
| 110 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.90618469 |
| 111 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.90595303 |
| 112 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90413824 |
| 113 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.90156406 |
| 114 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89802838 |
| 115 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.89368120 |
| 116 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89137769 |
| 117 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88813711 |
| 118 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.88501982 |
| 119 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.88429722 |
| 120 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.87713453 |
| 121 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.87643670 |
| 122 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.87322284 |
| 123 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87116743 |
| 124 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.85706993 |
| 125 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.83603565 |
| 126 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.82093856 |
| 127 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.81848181 |
| 128 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.81757580 |
| 129 | VDR_22108803_ChIP-Seq_LS180_Human | 0.80977884 |
| 130 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.80422413 |
| 131 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.79830466 |
| 132 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.77763699 |
| 133 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.77191311 |
| 134 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.76415545 |
| 135 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.67683187 |
| 136 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.66643925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 5.37129492 |
| 2 | MP0003186_abnormal_redox_activity | 4.41206898 |
| 3 | MP0006036_abnormal_mitochondrial_physio | 3.53721609 |
| 4 | MP0005360_urolithiasis | 3.41093000 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 2.85001985 |
| 6 | MP0005332_abnormal_amino_acid | 2.58139718 |
| 7 | MP0002132_abnormal_respiratory_system | 2.52311103 |
| 8 | MP0004043_abnormal_pH_regulation | 2.49725327 |
| 9 | MP0005451_abnormal_body_composition | 2.47839573 |
| 10 | MP0006292_abnormal_olfactory_placode | 2.47625500 |
| 11 | MP0008058_abnormal_DNA_repair | 2.46691659 |
| 12 | MP0005636_abnormal_mineral_homeostasis | 2.40333076 |
| 13 | MP0009379_abnormal_foot_pigmentation | 2.39107290 |
| 14 | MP0004147_increased_porphyrin_level | 2.37703935 |
| 15 | MP0005377_hearing/vestibular/ear_phenot | 2.30176283 |
| 16 | MP0003878_abnormal_ear_physiology | 2.30176283 |
| 17 | MP0005408_hypopigmentation | 2.28386363 |
| 18 | MP0005085_abnormal_gallbladder_physiolo | 2.24353333 |
| 19 | MP0000749_muscle_degeneration | 2.10114184 |
| 20 | MP0003880_abnormal_central_pattern | 2.09053772 |
| 21 | MP0009643_abnormal_urine_homeostasis | 2.08920592 |
| 22 | MP0003195_calcinosis | 2.08199256 |
| 23 | MP0003656_abnormal_erythrocyte_physiolo | 1.98005837 |
| 24 | MP0003786_premature_aging | 1.97232261 |
| 25 | MP0001756_abnormal_urination | 1.95994933 |
| 26 | MP0002938_white_spotting | 1.92666407 |
| 27 | MP0001764_abnormal_homeostasis | 1.88619612 |
| 28 | MP0003136_yellow_coat_color | 1.88339293 |
| 29 | MP0008875_abnormal_xenobiotic_pharmacok | 1.83752489 |
| 30 | MP0006035_abnormal_mitochondrial_morpho | 1.83226915 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.81959024 |
| 32 | MP0003011_delayed_dark_adaptation | 1.80043639 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.78692200 |
| 34 | MP0001542_abnormal_bone_strength | 1.77592966 |
| 35 | MP0002277_abnormal_respiratory_mucosa | 1.76852198 |
| 36 | MP0003693_abnormal_embryo_hatching | 1.69735506 |
| 37 | MP0004782_abnormal_surfactant_physiolog | 1.69598592 |
| 38 | MP0010094_abnormal_chromosome_stability | 1.68454095 |
| 39 | MP0002736_abnormal_nociception_after | 1.66094250 |
| 40 | MP0004019_abnormal_vitamin_homeostasis | 1.64556093 |
| 41 | MP0009046_muscle_twitch | 1.58969033 |
| 42 | MP0001984_abnormal_olfaction | 1.58819578 |
| 43 | MP0005083_abnormal_biliary_tract | 1.56302190 |
| 44 | MP0006072_abnormal_retinal_apoptosis | 1.56092062 |
| 45 | MP0008775_abnormal_heart_ventricle | 1.54004153 |
| 46 | MP0003111_abnormal_nucleus_morphology | 1.53560268 |
| 47 | MP0008877_abnormal_DNA_methylation | 1.53481105 |
| 48 | MP0002822_catalepsy | 1.50482911 |
| 49 | MP0003941_abnormal_skin_development | 1.50132014 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.49749531 |
| 51 | MP0008995_early_reproductive_senescence | 1.44446729 |
| 52 | MP0005084_abnormal_gallbladder_morpholo | 1.42520587 |
| 53 | MP0003077_abnormal_cell_cycle | 1.38977336 |
| 54 | MP0002102_abnormal_ear_morphology | 1.37882967 |
| 55 | MP0005319_abnormal_enzyme/_coenzyme | 1.37220332 |
| 56 | MP0009745_abnormal_behavioral_response | 1.35022189 |
| 57 | MP0002638_abnormal_pupillary_reflex | 1.34712857 |
| 58 | MP0005551_abnormal_eye_electrophysiolog | 1.34087737 |
| 59 | MP0000343_altered_response_to | 1.32416945 |
| 60 | MP0001529_abnormal_vocalization | 1.31794509 |
| 61 | MP0005330_cardiomyopathy | 1.30946389 |
| 62 | MP0005266_abnormal_metabolism | 1.30380038 |
| 63 | MP0005379_endocrine/exocrine_gland_phen | 1.29761997 |
| 64 | MP0001663_abnormal_digestive_system | 1.29570188 |
| 65 | MP0002734_abnormal_mechanical_nocicepti | 1.28514921 |
| 66 | MP0002272_abnormal_nervous_system | 1.26577438 |
| 67 | MP0001485_abnormal_pinna_reflex | 1.25188507 |
| 68 | MP0005365_abnormal_bile_salt | 1.25022947 |
| 69 | MP0009785_altered_susceptibility_to | 1.23849345 |
| 70 | MP0000372_irregular_coat_pigmentation | 1.23077240 |
| 71 | MP0008007_abnormal_cellular_replicative | 1.22550250 |
| 72 | MP0005646_abnormal_pituitary_gland | 1.22158866 |
| 73 | MP0002972_abnormal_cardiac_muscle | 1.21558824 |
| 74 | MP0005376_homeostasis/metabolism_phenot | 1.19649115 |
| 75 | MP0003646_muscle_fatigue | 1.17635671 |
| 76 | MP0000490_abnormal_crypts_of | 1.16230551 |
| 77 | MP0008872_abnormal_physiological_respon | 1.15906154 |
| 78 | MP0002090_abnormal_vision | 1.15759155 |
| 79 | MP0006276_abnormal_autonomic_nervous | 1.14139467 |
| 80 | MP0001293_anophthalmia | 1.13998614 |
| 81 | MP0003718_maternal_effect | 1.13287221 |
| 82 | MP0003436_decreased_susceptibility_to | 1.09741387 |
| 83 | MP0005670_abnormal_white_adipose | 1.09620257 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 1.09598002 |
| 85 | MP0002138_abnormal_hepatobiliary_system | 1.09338674 |
| 86 | MP0002064_seizures | 1.09058009 |
| 87 | MP0005423_abnormal_somatic_nervous | 1.07984847 |
| 88 | MP0001188_hyperpigmentation | 1.07371901 |
| 89 | MP0005535_abnormal_body_temperature | 1.07267963 |
| 90 | MP0003123_paternal_imprinting | 1.05258208 |
| 91 | MP0001905_abnormal_dopamine_level | 1.04991502 |
| 92 | MP0000230_abnormal_systemic_arterial | 1.04222125 |
| 93 | MP0004084_abnormal_cardiac_muscle | 1.03810073 |
| 94 | MP0004133_heterotaxia | 1.03441440 |
| 95 | MP0003121_genomic_imprinting | 1.02626506 |
| 96 | MP0000631_abnormal_neuroendocrine_gland | 0.99811590 |
| 97 | MP0009697_abnormal_copulation | 0.99705696 |
| 98 | MP0009840_abnormal_foam_cell | 0.99694175 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.98664606 |
| 100 | MP0004270_analgesia | 0.98446269 |
| 101 | MP0000858_altered_metastatic_potential | 0.97727656 |
| 102 | MP0000358_abnormal_cell_content/ | 0.97720556 |
| 103 | MP0001666_abnormal_nutrient_absorption | 0.97644120 |
| 104 | MP0003787_abnormal_imprinting | 0.97006990 |
| 105 | MP0003938_abnormal_ear_development | 0.95892124 |
| 106 | MP0002909_abnormal_adrenal_gland | 0.95784167 |
| 107 | MP0005075_abnormal_melanosome_morpholog | 0.95598265 |
| 108 | MP0005381_digestive/alimentary_phenotyp | 0.95488850 |
| 109 | MP0000647_abnormal_sebaceous_gland | 0.94953321 |
| 110 | MP0009764_decreased_sensitivity_to | 0.94822989 |
| 111 | MP0006054_spinal_hemorrhage | 0.94260263 |
| 112 | MP0002210_abnormal_sex_determination | 0.94217358 |
| 113 | MP0004957_abnormal_blastocyst_morpholog | 0.94119450 |
| 114 | MP0008469_abnormal_protein_level | 0.93448087 |
| 115 | MP0005253_abnormal_eye_physiology | 0.92947943 |
| 116 | MP0003191_abnormal_cellular_cholesterol | 0.92839530 |
| 117 | MP0002295_abnormal_pulmonary_circulatio | 0.91695959 |
| 118 | MP0001970_abnormal_pain_threshold | 0.90538080 |
| 119 | MP0001346_abnormal_lacrimal_gland | 0.90399524 |
| 120 | MP0003315_abnormal_perineum_morphology | 0.88946101 |
| 121 | MP0005645_abnormal_hypothalamus_physiol | 0.88134955 |
| 122 | MP0005166_decreased_susceptibility_to | 0.87016266 |
| 123 | MP0002095_abnormal_skin_pigmentation | 0.87001605 |
| 124 | MP0004272_abnormal_basement_membrane | 0.86653035 |
| 125 | MP0001544_abnormal_cardiovascular_syste | 0.85663486 |
| 126 | MP0005385_cardiovascular_system_phenoty | 0.85663486 |
| 127 | MP0003724_increased_susceptibility_to | 0.85647864 |
| 128 | MP0002118_abnormal_lipid_homeostasis | 0.85235913 |
| 129 | MP0002557_abnormal_social/conspecific_i | 0.84250693 |
| 130 | MP0002653_abnormal_ependyma_morphology | 0.84126153 |
| 131 | MP0001919_abnormal_reproductive_system | 0.83447952 |
| 132 | MP0008932_abnormal_embryonic_tissue | 0.82912793 |
| 133 | MP0005389_reproductive_system_phenotype | 0.82259526 |
| 134 | MP0002572_abnormal_emotion/affect_behav | 0.81928818 |
| 135 | MP0010386_abnormal_urinary_bladder | 0.80384485 |
| 136 | MP0010329_abnormal_lipoprotein_level | 0.79529845 |
| 137 | MP0005394_taste/olfaction_phenotype | 0.78540733 |
| 138 | MP0005499_abnormal_olfactory_system | 0.78540733 |
| 139 | MP0001486_abnormal_startle_reflex | 0.77858188 |
| 140 | MP0001929_abnormal_gametogenesis | 0.77713701 |
| 141 | MP0003221_abnormal_cardiomyocyte_apopto | 0.77351197 |
| 142 | MP0002735_abnormal_chemical_nociception | 0.77262528 |
| 143 | MP0003122_maternal_imprinting | 0.76514906 |
| 144 | MP0002163_abnormal_gland_morphology | 0.75929580 |
| 145 | MP0009333_abnormal_splenocyte_physiolog | 0.74421620 |
| 146 | MP0004142_abnormal_muscle_tone | 0.73814451 |
| 147 | MP0005164_abnormal_response_to | 0.73382079 |
| 148 | MP0009642_abnormal_blood_homeostasis | 0.72645412 |
| 149 | MP0006082_CNS_inflammation | 0.72496466 |
| 150 | MP0001765_abnormal_ion_homeostasis | 0.72062466 |
| 151 | MP0004883_abnormal_blood_vessel | 0.71154450 |
| 152 | MP0008789_abnormal_olfactory_epithelium | 0.70981869 |
| 153 | MP0010030_abnormal_orbit_morphology | 0.69253296 |
| 154 | MP0003879_abnormal_hair_cell | 0.69021162 |
| 155 | MP0001968_abnormal_touch/_nociception | 0.68932094 |
| 156 | MP0010155_abnormal_intestine_physiology | 0.68805890 |
| 157 | MP0002160_abnormal_reproductive_system | 0.68025761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 6.82265046 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 6.36926255 |
| 3 | Acute encephalopathy (HP:0006846) | 6.10153363 |
| 4 | Progressive macrocephaly (HP:0004481) | 5.57037444 |
| 5 | Mitochondrial inheritance (HP:0001427) | 5.56883770 |
| 6 | Increased CSF lactate (HP:0002490) | 4.90593506 |
| 7 | Hepatic necrosis (HP:0002605) | 4.89937094 |
| 8 | Hepatocellular necrosis (HP:0001404) | 4.65099720 |
| 9 | Cerebral edema (HP:0002181) | 4.49175251 |
| 10 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.30014786 |
| 11 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.30014786 |
| 12 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.93746825 |
| 13 | Respiratory failure (HP:0002878) | 3.70575032 |
| 14 | Exercise intolerance (HP:0003546) | 3.64698292 |
| 15 | Lactic acidosis (HP:0003128) | 3.57169412 |
| 16 | Lipid accumulation in hepatocytes (HP:0006561) | 3.46771459 |
| 17 | Increased hepatocellular lipid droplets (HP:0006565) | 3.45336460 |
| 18 | Generalized aminoaciduria (HP:0002909) | 3.44487239 |
| 19 | Increased muscle lipid content (HP:0009058) | 3.39407920 |
| 20 | Increased intramyocellular lipid droplets (HP:0012240) | 3.36619750 |
| 21 | Glycosuria (HP:0003076) | 3.33901873 |
| 22 | Abnormality of urine glucose concentration (HP:0011016) | 3.33901873 |
| 23 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.30091398 |
| 24 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.23070572 |
| 25 | Increased serum lactate (HP:0002151) | 3.21188227 |
| 26 | Abnormal number of erythroid precursors (HP:0012131) | 3.20640824 |
| 27 | Leukodystrophy (HP:0002415) | 3.10674558 |
| 28 | Nausea (HP:0002018) | 3.06979484 |
| 29 | Lethargy (HP:0001254) | 3.04551886 |
| 30 | Conjunctival hamartoma (HP:0100780) | 3.00889336 |
| 31 | Proximal tubulopathy (HP:0000114) | 2.98009613 |
| 32 | Renal Fanconi syndrome (HP:0001994) | 2.94580133 |
| 33 | Neuroendocrine neoplasm (HP:0100634) | 2.92469466 |
| 34 | Pheochromocytoma (HP:0002666) | 2.91677475 |
| 35 | Optic disc pallor (HP:0000543) | 2.84932684 |
| 36 | Dicarboxylic aciduria (HP:0003215) | 2.81773379 |
| 37 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.81773379 |
| 38 | Hyperphosphaturia (HP:0003109) | 2.81046285 |
| 39 | Increased serum pyruvate (HP:0003542) | 2.78551973 |
| 40 | Abnormality of glycolysis (HP:0004366) | 2.78551973 |
| 41 | Neoplasm of the adrenal gland (HP:0100631) | 2.77752742 |
| 42 | 3-Methylglutaconic aciduria (HP:0003535) | 2.72631715 |
| 43 | Exertional dyspnea (HP:0002875) | 2.71698821 |
| 44 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.64393309 |
| 45 | Vomiting (HP:0002013) | 2.60853677 |
| 46 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.59047202 |
| 47 | Abnormal tarsal ossification (HP:0008369) | 2.52791338 |
| 48 | Ileus (HP:0002595) | 2.51707778 |
| 49 | Type I transferrin isoform profile (HP:0003642) | 2.44041615 |
| 50 | Cerebral hypomyelination (HP:0006808) | 2.39481164 |
| 51 | Methylmalonic acidemia (HP:0002912) | 2.38742413 |
| 52 | Myokymia (HP:0002411) | 2.36764336 |
| 53 | Renal tubular dysfunction (HP:0000124) | 2.32931555 |
| 54 | Palpitations (HP:0001962) | 2.32389030 |
| 55 | Abnormality of renal resorption (HP:0011038) | 2.31496278 |
| 56 | Abnormality of the anterior horn cell (HP:0006802) | 2.30486435 |
| 57 | Degeneration of anterior horn cells (HP:0002398) | 2.30486435 |
| 58 | Irregular epiphyses (HP:0010582) | 2.29584163 |
| 59 | Hypoglycemic coma (HP:0001325) | 2.28211058 |
| 60 | Diaphragmatic weakness (HP:0009113) | 2.26191247 |
| 61 | Abnormality of magnesium homeostasis (HP:0004921) | 2.24077724 |
| 62 | CNS demyelination (HP:0007305) | 2.23991112 |
| 63 | Aplastic anemia (HP:0001915) | 2.23224353 |
| 64 | Abnormal urine phosphate concentration (HP:0012599) | 2.22313390 |
| 65 | Hyperactive renin-angiotensin system (HP:0000841) | 2.21737002 |
| 66 | Hyperglycinemia (HP:0002154) | 2.19361008 |
| 67 | Pustule (HP:0200039) | 2.18994337 |
| 68 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.18858827 |
| 69 | Respiratory difficulties (HP:0002880) | 2.18722593 |
| 70 | Hyperglycinuria (HP:0003108) | 2.13652741 |
| 71 | Reticulocytopenia (HP:0001896) | 2.13291425 |
| 72 | Sparse eyelashes (HP:0000653) | 2.13198379 |
| 73 | Oral leukoplakia (HP:0002745) | 2.12474228 |
| 74 | Metabolic alkalosis (HP:0200114) | 2.11222496 |
| 75 | Congenital, generalized hypertrichosis (HP:0004540) | 2.05487902 |
| 76 | Abnormality of the labia minora (HP:0012880) | 2.04646459 |
| 77 | Abnormality of alanine metabolism (HP:0010916) | 2.02564526 |
| 78 | Hyperalaninemia (HP:0003348) | 2.02564526 |
| 79 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.02564526 |
| 80 | Abnormality of methionine metabolism (HP:0010901) | 2.00499225 |
| 81 | Abnormality of serum amino acid levels (HP:0003112) | 1.99981871 |
| 82 | Delayed epiphyseal ossification (HP:0002663) | 1.99674294 |
| 83 | Alkalosis (HP:0001948) | 1.99158402 |
| 84 | Metabolic acidosis (HP:0001942) | 1.98176037 |
| 85 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.97318247 |
| 86 | Abnormal gallbladder physiology (HP:0012438) | 1.95696560 |
| 87 | Cholecystitis (HP:0001082) | 1.95696560 |
| 88 | Abnormal protein glycosylation (HP:0012346) | 1.95432677 |
| 89 | Abnormal glycosylation (HP:0012345) | 1.95432677 |
| 90 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.95432677 |
| 91 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.95432677 |
| 92 | Microvesicular hepatic steatosis (HP:0001414) | 1.94380976 |
| 93 | Methylmalonic aciduria (HP:0012120) | 1.94049779 |
| 94 | Emotional lability (HP:0000712) | 1.93161159 |
| 95 | Patent foramen ovale (HP:0001655) | 1.92177104 |
| 96 | Colon cancer (HP:0003003) | 1.92069985 |
| 97 | Pancytopenia (HP:0001876) | 1.90249113 |
| 98 | Hyperammonemia (HP:0001987) | 1.89068710 |
| 99 | X-linked dominant inheritance (HP:0001423) | 1.89049248 |
| 100 | Multiple enchondromatosis (HP:0005701) | 1.86753493 |
| 101 | Megaloblastic anemia (HP:0001889) | 1.86459987 |
| 102 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.85900929 |
| 103 | Testicular atrophy (HP:0000029) | 1.82891737 |
| 104 | Macrocytic anemia (HP:0001972) | 1.82578856 |
| 105 | Pancreatic fibrosis (HP:0100732) | 1.82513658 |
| 106 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.82326654 |
| 107 | Poor suck (HP:0002033) | 1.81126698 |
| 108 | Renal salt wasting (HP:0000127) | 1.80649580 |
| 109 | Renal tubular acidosis (HP:0001947) | 1.76941290 |
| 110 | Pallor (HP:0000980) | 1.74606215 |
| 111 | Rhabdomyolysis (HP:0003201) | 1.74561299 |
| 112 | Petechiae (HP:0000967) | 1.73450192 |
| 113 | CNS hypomyelination (HP:0003429) | 1.73166683 |
| 114 | Hypokalemic alkalosis (HP:0001949) | 1.73122887 |
| 115 | Hyperbilirubinemia (HP:0002904) | 1.72826867 |
| 116 | Pancreatic cysts (HP:0001737) | 1.72301027 |
| 117 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.72031972 |
| 118 | Carpal bone hypoplasia (HP:0001498) | 1.71745478 |
| 119 | Abnormality of chloride homeostasis (HP:0011422) | 1.71263447 |
| 120 | Redundant skin (HP:0001582) | 1.71094481 |
| 121 | Abnormality of carpal bone ossification (HP:0006257) | 1.70760028 |
| 122 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.70524236 |
| 123 | Septo-optic dysplasia (HP:0100842) | 1.70379641 |
| 124 | Bone cyst (HP:0012062) | 1.69436875 |
| 125 | Hydroxyprolinuria (HP:0003080) | 1.69057505 |
| 126 | Abnormality of proline metabolism (HP:0010907) | 1.69057505 |
| 127 | Sclerocornea (HP:0000647) | 1.68863569 |
| 128 | Poor head control (HP:0002421) | 1.68036157 |
| 129 | Abnormality of midbrain morphology (HP:0002418) | 1.68004114 |
| 130 | Molar tooth sign on MRI (HP:0002419) | 1.68004114 |
| 131 | Delayed CNS myelination (HP:0002188) | 1.66617053 |
| 132 | Neoplasm of head and neck (HP:0012288) | 1.65904607 |
| 133 | Esophageal neoplasm (HP:0100751) | 1.65904607 |
| 134 | Hyperaldosteronism (HP:0000859) | 1.65866463 |
| 135 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.64609107 |
| 136 | Hypokinesia (HP:0002375) | 1.63578658 |
| 137 | Abnormality of vitamin B metabolism (HP:0004340) | 1.63495486 |
| 138 | Blindness (HP:0000618) | 1.63226351 |
| 139 | Abnormality of the vocal cords (HP:0008777) | 1.62599914 |
| 140 | Amniotic constriction ring (HP:0009775) | 1.62534059 |
| 141 | Abnormality of placental membranes (HP:0011409) | 1.62534059 |
| 142 | Gliosis (HP:0002171) | 1.61064041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.81224616 |
| 2 | CDK19 | 4.55402335 |
| 3 | NME2 | 3.57972125 |
| 4 | ARAF | 3.38089682 |
| 5 | PIM2 | 3.32814278 |
| 6 | TESK1 | 3.29575203 |
| 7 | MYLK | 3.10415726 |
| 8 | BCKDK | 2.86177193 |
| 9 | PDK2 | 2.71303313 |
| 10 | LIMK1 | 2.66934800 |
| 11 | NME1 | 2.33660812 |
| 12 | OBSCN | 2.29809459 |
| 13 | ZAK | 2.24296807 |
| 14 | CDC7 | 2.14030475 |
| 15 | STK16 | 2.11449944 |
| 16 | STK38L | 2.00700427 |
| 17 | PIK3CA | 1.92135911 |
| 18 | ABL2 | 1.90676620 |
| 19 | TESK2 | 1.85801300 |
| 20 | MAP3K12 | 1.81684776 |
| 21 | EIF2AK1 | 1.75667619 |
| 22 | BRAF | 1.74038085 |
| 23 | STK24 | 1.73843854 |
| 24 | MAP3K11 | 1.69192563 |
| 25 | WNK4 | 1.65610899 |
| 26 | PBK | 1.62906057 |
| 27 | PLK4 | 1.62146993 |
| 28 | NEK1 | 1.62101465 |
| 29 | NUAK1 | 1.55324141 |
| 30 | VRK1 | 1.54092824 |
| 31 | DAPK3 | 1.53907559 |
| 32 | TLK1 | 1.51902416 |
| 33 | TRIM28 | 1.46317719 |
| 34 | BUB1 | 1.46112097 |
| 35 | KDR | 1.35474092 |
| 36 | SIK3 | 1.33293441 |
| 37 | GRK5 | 1.31022053 |
| 38 | MST4 | 1.28544857 |
| 39 | LMTK2 | 1.27836675 |
| 40 | PRKG2 | 1.23609102 |
| 41 | MAP4K2 | 1.22572161 |
| 42 | ILK | 1.21820999 |
| 43 | CSNK1G3 | 1.18213028 |
| 44 | MAP3K14 | 1.15423447 |
| 45 | BMPR2 | 1.13399434 |
| 46 | MST1R | 1.12768990 |
| 47 | BRSK1 | 1.06695764 |
| 48 | EPHA4 | 1.06398013 |
| 49 | CSNK1G1 | 1.05700530 |
| 50 | EPHB2 | 1.01645517 |
| 51 | CSNK1G2 | 1.01061722 |
| 52 | BCR | 0.98237300 |
| 53 | GRK1 | 0.97840660 |
| 54 | MAP2K7 | 0.97562232 |
| 55 | TAF1 | 0.97194422 |
| 56 | IRAK3 | 0.97060681 |
| 57 | BRSK2 | 0.94631016 |
| 58 | WNK3 | 0.90489330 |
| 59 | TNIK | 0.83480485 |
| 60 | EPHA2 | 0.83055176 |
| 61 | CASK | 0.82109569 |
| 62 | CSNK1A1L | 0.81204873 |
| 63 | MAP3K10 | 0.80613277 |
| 64 | PRKCG | 0.79848110 |
| 65 | MAP2K2 | 0.76454894 |
| 66 | TSSK6 | 0.76269818 |
| 67 | PAK1 | 0.75016202 |
| 68 | CDK11A | 0.72118849 |
| 69 | MAP2K6 | 0.71799328 |
| 70 | MAP3K3 | 0.71208699 |
| 71 | CSNK2A2 | 0.70188155 |
| 72 | OXSR1 | 0.69923813 |
| 73 | CHEK2 | 0.66914625 |
| 74 | STK4 | 0.66759591 |
| 75 | MINK1 | 0.65700751 |
| 76 | ATR | 0.65114955 |
| 77 | MARK3 | 0.64235971 |
| 78 | AURKA | 0.63418969 |
| 79 | PRKCI | 0.62113423 |
| 80 | MAP2K3 | 0.57782092 |
| 81 | CCNB1 | 0.56570543 |
| 82 | MAP2K1 | 0.56106175 |
| 83 | CDK18 | 0.56028792 |
| 84 | CAMK2G | 0.55602849 |
| 85 | CDK14 | 0.55334603 |
| 86 | PHKG2 | 0.55130481 |
| 87 | PHKG1 | 0.55130481 |
| 88 | RPS6KA5 | 0.55006389 |
| 89 | CDK8 | 0.54892029 |
| 90 | INSRR | 0.53900380 |
| 91 | PINK1 | 0.53369608 |
| 92 | EIF2AK3 | 0.52959914 |
| 93 | RIPK4 | 0.51736753 |
| 94 | PIM1 | 0.51025490 |
| 95 | ERN1 | 0.50772842 |
| 96 | PAK3 | 0.50176375 |
| 97 | LRRK2 | 0.50104545 |
| 98 | NEK9 | 0.49792704 |
| 99 | MUSK | 0.49776167 |
| 100 | STK39 | 0.49523860 |
| 101 | TBK1 | 0.49466921 |
| 102 | PLK2 | 0.49352448 |
| 103 | CSNK1A1 | 0.49085298 |
| 104 | IRAK4 | 0.47952462 |
| 105 | CDK15 | 0.46943799 |
| 106 | CSNK1E | 0.46728822 |
| 107 | ADRBK2 | 0.46481364 |
| 108 | PRKCD | 0.46440120 |
| 109 | CSNK2A1 | 0.45970146 |
| 110 | DYRK2 | 0.43866734 |
| 111 | PLK3 | 0.43079616 |
| 112 | MAPKAPK5 | 0.42450965 |
| 113 | CAMK2D | 0.42033523 |
| 114 | DAPK1 | 0.40509687 |
| 115 | MAPKAPK3 | 0.40261383 |
| 116 | WEE1 | 0.36758172 |
| 117 | AURKB | 0.36381116 |
| 118 | MKNK2 | 0.35760719 |
| 119 | MAP3K8 | 0.35731002 |
| 120 | PRKCE | 0.35575248 |
| 121 | MAP3K4 | 0.35171166 |
| 122 | CAMK2A | 0.34452331 |
| 123 | PLK1 | 0.33160275 |
| 124 | ERBB3 | 0.32899315 |
| 125 | MAPK13 | 0.32297285 |
| 126 | CDC42BPA | 0.29601724 |
| 127 | RAF1 | 0.29141399 |
| 128 | IKBKB | 0.28810183 |
| 129 | TAOK1 | 0.28602736 |
| 130 | TAOK2 | 0.27347101 |
| 131 | BMPR1B | 0.26673366 |
| 132 | EIF2AK2 | 0.25277168 |
| 133 | ROCK1 | 0.25211793 |
| 134 | ADRBK1 | 0.25173671 |
| 135 | SRPK1 | 0.24505604 |
| 136 | PAK4 | 0.23680345 |
| 137 | TRPM7 | 0.22764582 |
| 138 | PRKCA | 0.22320351 |
| 139 | TTK | 0.22020370 |
| 140 | KSR2 | 0.21700880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.45866977 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.88765405 |
| 3 | Huntingtons disease_Homo sapiens_hsa05016 | 3.44160409 |
| 4 | Alzheimers disease_Homo sapiens_hsa05010 | 3.34512775 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.18606722 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 3.16595844 |
| 7 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 3.16282694 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.90887580 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.81982604 |
| 10 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.34005230 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.09654887 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.92009953 |
| 13 | Protein export_Homo sapiens_hsa03060 | 1.87408426 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.76192804 |
| 15 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.67569814 |
| 16 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.64389713 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 1.62747150 |
| 18 | Sulfur relay system_Homo sapiens_hsa04122 | 1.53713160 |
| 19 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.53110589 |
| 20 | Carbon metabolism_Homo sapiens_hsa01200 | 1.53031889 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.51811594 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.50371871 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.48768406 |
| 24 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.45239376 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.43422116 |
| 26 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.31904698 |
| 27 | DNA replication_Homo sapiens_hsa03030 | 1.29273062 |
| 28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.29134783 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.27600777 |
| 30 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.25805771 |
| 31 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.16239507 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.14930042 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.14387588 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.11702600 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.10970633 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.10113022 |
| 37 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.07933087 |
| 38 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.06208330 |
| 39 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.05973681 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.05444086 |
| 41 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.05126004 |
| 42 | RNA transport_Homo sapiens_hsa03013 | 1.04615188 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.04527502 |
| 44 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.03237850 |
| 45 | Basal transcription factors_Homo sapiens_hsa03022 | 1.02675966 |
| 46 | RNA degradation_Homo sapiens_hsa03018 | 1.00914329 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.98970062 |
| 48 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.97285634 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.94192442 |
| 50 | Mismatch repair_Homo sapiens_hsa03430 | 0.93631380 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 0.93015818 |
| 52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.92948111 |
| 53 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.92832472 |
| 54 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.91390471 |
| 55 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.89056594 |
| 56 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88761708 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.88235889 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.87448320 |
| 59 | Mineral absorption_Homo sapiens_hsa04978 | 0.87276687 |
| 60 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85992765 |
| 61 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83309162 |
| 62 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.82195499 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81667872 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.78196156 |
| 65 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78026315 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76459743 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.71660210 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68410736 |
| 69 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.64119982 |
| 70 | Base excision repair_Homo sapiens_hsa03410 | 0.61773519 |
| 71 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61177754 |
| 72 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.61119670 |
| 73 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60800269 |
| 74 | Homologous recombination_Homo sapiens_hsa03440 | 0.60662444 |
| 75 | Purine metabolism_Homo sapiens_hsa00230 | 0.59771829 |
| 76 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59003936 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57090269 |
| 78 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.57033438 |
| 79 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56759690 |
| 80 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.56139487 |
| 81 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.55416217 |
| 82 | Phototransduction_Homo sapiens_hsa04744 | 0.54701200 |
| 83 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52314248 |
| 84 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.48656677 |
| 85 | Nicotine addiction_Homo sapiens_hsa05033 | 0.48107620 |
| 86 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.47916266 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.47478923 |
| 88 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.46684881 |
| 89 | Cell cycle_Homo sapiens_hsa04110 | 0.41931701 |
| 90 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.40698327 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40175933 |
| 92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.39089720 |
| 93 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.37810869 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37598188 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.36701836 |
| 96 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.34600288 |
| 97 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.34516565 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.34498256 |
| 99 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.33054805 |
| 100 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.33035692 |
| 101 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.30492242 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.29585826 |
| 103 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29277361 |
| 104 | Legionellosis_Homo sapiens_hsa05134 | 0.29018787 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27198839 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25952590 |
| 107 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.23934321 |
| 108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23183003 |
| 109 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.20156660 |
| 110 | Asthma_Homo sapiens_hsa05310 | 0.18532106 |
| 111 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.17715152 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.17282052 |
| 113 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.16822264 |
| 114 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.16284485 |
| 115 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.15715278 |
| 116 | Bile secretion_Homo sapiens_hsa04976 | 0.15462029 |
| 117 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.14649709 |
| 118 | Retinol metabolism_Homo sapiens_hsa00830 | 0.13776744 |
| 119 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.12874695 |
| 120 | Spliceosome_Homo sapiens_hsa03040 | 0.12815898 |

